IndomethacinChemistry, PharmaceuticalCyclooxygenase InhibitorsAnti-Inflammatory Agents, Non-SteroidalProstaglandinsDelayed-Action PreparationsDrug CompoundingExcipientsTabletsDosage FormsDinoprostoneProstaglandins EDrug CarriersTechnology, PharmaceuticalEmulsionsDrug StabilityProstaglandin-Endoperoxide SynthasesCapsulesParticle SizeTherapeutic EquivalencySolubilityBiological AvailabilityIbuprofenDrug Delivery SystemsPowdersProstaglandin AntagonistsDose-Response Relationship, DrugDuctus Arteriosus, PatentPharmaceutical VehiclesSkin AbsorptionPharmaceutical SolutionsCyclooxygenase 1Administration, Oral4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amineNanoparticlesStomach UlcerMethylcelluloseArachidonic AcidsLiposomesGastric MucosaSuspensionsAdministration, Topical6-Ketoprostaglandin F1 alphaMasoprocolMeclofenamic AcidArachidonic AcidProstaglandins FEpoprostenolCyclooxygenase 2RabbitsFreeze DryingAspirinLipoxygenase InhibitorsBradykininDiclofenacRats, Wistar16,16-Dimethylprostaglandin E2Cyclooxygenase 2 InhibitorsVasodilationBiological FactorsDrug StorageAdministration, CutaneousRats, Sprague-DawleyNitrobenzenesPiroxicamNitric Oxide5,8,11,14-Eicosatetraynoic AcidGuinea PigsGelsNG-Nitroarginine Methyl EsterKetoprofenNitroarginineTime FactorsPolysorbatesThromboxane B2Drug CombinationsPharmaceutical PreparationsPoloxamerSuppositoriesDrug InteractionsSurface-Active AgentsSulfonamidesPolyglycolic AcidMuscle RelaxationThromboxane A2AcetylcholineRats, Inbred StrainsAnti-Inflammatory AgentsPolyethylene GlycolsVasoconstrictionEmulsifying AgentsDuctus ArteriosusProstaglandins E, SyntheticArea Under CurvePyrazolesEdemaDinoprostCross-Over StudiesMuscle ContractionChromatography, High Pressure Liquid